Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Eder

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Important Advances in Oncology|January 1, 1987
High-dose chemotherapy with bone marrow support for solid tumorsK Antman, J P Eder, E Frei
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
BET inhibitors: a novel epigenetic approachD B Doroshow, J P Eder, P M LoRusso
Cancer Research|November 1, 1990
Phase I trial of escalating pentoxifylline dose with constant dose thiotepaB J Dezube, J P Eder, A B Pardee
The Journal of Biological Chemistry|January 25, 1993
Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell lineV T Chan, S W Ng, J P Eder, et al.
Cancer Research|January 15, 1991
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicityJ P Eder, C A Wheeler, B A Teicher, et al.
The Journal of Biological Chemistry|October 27, 1995
Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase II alpha geneS W Ng, J P Eder, L E Schnipper, et al.
The Journal of Biological Chemistry|July 5, 1993
Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cellsJ P Eder, V T Chan, E Niemierko, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Influence of scheduling on two-drug combinations of alkylating agents in vivoB A Teicher, S A Holden, S M Jones, et al.
Cancer Treatment Reports|July 1, 1986
Pharmacokinetics and immediate effects of high-dose carmustine in manW D Henner, W P Peters, J P Eder, et al.
The Journal of Clinical Investigation|May 1, 1987
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine modelJ P Eder, B A Teicher, S A Holden, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Important Advances in Oncology|January 1, 1987
High-dose chemotherapy with bone marrow support for solid tumorsK Antman, J P Eder, E Frei
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
BET inhibitors: a novel epigenetic approachD B Doroshow, J P Eder, P M LoRusso
Cancer Research|November 1, 1990
Phase I trial of escalating pentoxifylline dose with constant dose thiotepaB J Dezube, J P Eder, A B Pardee
The Journal of Biological Chemistry|January 25, 1993
Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell lineV T Chan, S W Ng, J P Eder, et al.
Cancer Research|January 15, 1991
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicityJ P Eder, C A Wheeler, B A Teicher, et al.
The Journal of Biological Chemistry|October 27, 1995
Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase II alpha geneS W Ng, J P Eder, L E Schnipper, et al.
The Journal of Biological Chemistry|July 5, 1993
Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cellsJ P Eder, V T Chan, E Niemierko, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Influence of scheduling on two-drug combinations of alkylating agents in vivoB A Teicher, S A Holden, S M Jones, et al.
Cancer Treatment Reports|July 1, 1986
Pharmacokinetics and immediate effects of high-dose carmustine in manW D Henner, W P Peters, J P Eder, et al.
The Journal of Clinical Investigation|May 1, 1987
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine modelJ P Eder, B A Teicher, S A Holden, et al.
Pageof 6